Title  |
Author |
Type |
Words |
| Abbott selected by JRC to partner in screening blood donations. |
|
|
155 |
| Acorda says secondary endpoints supportive of primary endpoint in INBRIJA trial. |
|
|
187 |
| Aemetis receives $12.7M tax exemption from CAEATFA for biofuels project. |
|
|
128 |
| Aerie Pharmaceuticals' IND Application for AR-1105 accepted by FDA. |
|
|
113 |
| Aerpio Pharmaceuticals completes patient dosing in TIME-2b study of AKB-9778. |
|
Clinical report |
160 |
| Alcoa price target lowered to $45 from $50 at BMO Capital. |
|
|
101 |
| Altria Group invests up to $12M to fund DehydraTECH technology from Lexaria. |
|
|
171 |
| Amazon search index points to in-line online retail revenue, says Piper Jaffray. |
|
|
117 |
| AMC Theatres announces AMC Stubs reaches over 18M member households. |
|
|
157 |
| American Express reports Q4 loan loss provisions $954M, up 14% from last year. |
|
Financial report |
173 |
| Arconic attracts call spreads and put spreads Thursday morning. |
|
|
121 |
| Ashland sends letter to shareholders recommending board nominees. |
|
|
193 |
| Asian Market Wrap:. |
|
|
194 |
| AT&T attracts put buying as shares advance. |
|
|
109 |
| Baxter announces 5M home PD treatments managed globally with Sharesource. |
|
|
264 |
| BB&T reports Q4 EPS ex-items $1.05, consensus $1.04. |
|
Financial report |
146 |
| Biscayne Bancshares shareholders approve merger with First Citizens. |
|
|
132 |
| Black employees sue GM claiming plant ignored racism, CNN reports. |
|
|
113 |
| BlackRock CEO calls on business leaders to tackle social issues, FT says. |
|
|
113 |
| Bryn Mawr Bank reports Q4 EPS 84c, consensus 80c. |
|
Financial report |
198 |
| Call butterfly in JP Morgan is similar to one in Wells Fargo. |
|
|
113 |
| Call buyers in Skechers as shares rally. |
|
|
102 |
| Canada CPI preview. |
|
|
195 |
| Canadian Solar to provide EPC services, solar modules to Australian solar farm. |
|
|
134 |
| Cannell says Lee Enterprises board 'devoid of skin in the game'. |
|
|
210 |
| Casa Systems sees Q4 EPS 13c-17c, consensus 20c. |
|
Financial report |
240 |
| CBS says Moonves demands binding arbitration over termination, severance. |
|
|
194 |
| Cellular Biomedicine announces AlloJoin approval for Phase 2 trial in China. |
|
|
101 |
| Celsion announces results from Phase 1 TARDOX trial published. |
|
|
438 |
| Cemtrex receives Nasdaq letter of non-compliance. |
|
|
267 |
| Cohen hired IT firm to hack CNBC, Drudge polls to favor Trump, WSJ reports. |
|
|
145 |
| Correvio provides update on at the market offering. |
|
|
179 |
| Deutsche Bank cuts price targets in containerboard space. |
|
|
114 |
| Dun & Bradstreet receives FCA approval in connection with proposed merger. |
|
|
153 |
| Earnings hedge in Atlassian Corporation. |
|
|
103 |
| Eastman Chemical upgraded to Overweight from Equal Weight at Morgan Stanley. |
|
|
102 |
| Essendant, Staples announce extension of tender offer for Essendant shares. |
|
|
187 |
| Euro$ interest rate futures rotated lower. |
|
|
112 |
| Facebook manager quirs after being 'harassed' over views, CNBC reports. |
|
|
122 |
| Facebook manager quits after being 'harassed' over views, CNBC reports. |
|
|
122 |
| Facebook poaches Google's Ryan Cairns to lead Portal. |
|
|
107 |
| Facebook says removed 471 pages, accounts for inauthentic behavior. |
|
|
202 |
| FDA advisory committee votes on Zynquista as treatments for adults with diabetes. |
|
|
125 |
| FDA commissioner describes efforts to support development of OTC naloxone. |
|
|
254 |
| FDA evaluating mortality information regarding paclitaxel balloons, stents. |
|
|
157 |
| Fed VC of Supervision Quarles said the economy is very strong. |
|
|
119 |
| Ferro lowers adjusted EPS view $1.45-$1.50 from $1.55-$1.60, consensus $1.56. |
|
|
254 |
| Fidelity Southern reports Q4 EPS 36c, consensus 33c. |
|
Financial report |
119 |
| Five Prime presents data from safety lead-in to Phase 3 FIGHT trial. |
|
|
181 |
| Fly Intel: After Hours Movers. |
|
|
116 |
| Fly Intel: Pre-market Movers. |
|
|
214 |
| Fly Intel: Top five analyst downgrades. |
|
|
166 |
| Fly Intel: Top five analyst initiations. |
|
|
136 |
| Fly Intel: Top five analyst upgrades. |
|
|
160 |
| Fly Intel: What to watch in credit card space earnings reports. |
|
Financial report |
502 |
| Fortuna reports FY18 production of 12.8 M silver equivalent ounces. |
|
|
133 |
| Fossil to sell select smartwatch technology to Google for $40M. |
|
|
147 |
| FX Action: The dollar largely gave back gains. |
|
|
232 |
| FX Update: An abatement in risk appetite has impacted currencies. |
|
|
208 |
| Gevo and Avfuel partner to supply sustainable jet fuel at Van Nuys Airport event. |
|
|
115 |
| Gol Linhas announces expiration time extension for tender offer by Gol Finance. |
|
|
143 |
| Goldman downgrades First Data to Neutral, keeps Buy rating on Fiserv. |
|
|
125 |
| Goldman Sachs condors on the heels of butterflies in major banks. |
|
|
133 |
| Goldman Sachs price target lowered to $262 from $276 at BMO Capital. |
|
|
104 |
| Great Panther Silver provides 2019 Mexican operations production and cost view. |
|
|
143 |
| Gulfport announces new $400M buyback, sees $100M in 2019 free cash flow. |
|
|
289 |
| Gulfport completes buyback, Q4 daily production average 1,392.8 MMcfe per day. |
|
|
244 |
| Helios and Matheson announces submission for proposed spin-off of MoviePass. |
|
|
224 |
| Honeywell selected for largest petrochemicals project in China. |
|
|
142 |
| Ideanomics signs agreement with CICC for NTC Electric City Bus upgrade. |
|
|
140 |
| Immunomedics receives response from FDA on Sacituzumab Govitecan BLA. |
|
|
133 |
| IMV Inc says first patient dosed in Phase 1 DPX-NEO program trial. |
|
|
107 |
| Insmed upgraded to Buy from Neutral at Goldman Sachs. |
|
|
110 |
| Jefferies downgrades Electronic Arts to Hold, cuts target to $95 from $139. |
|
|
101 |
| JMP says Goldman Sachs took 'big step' in repairing sentiment with Q4 report. |
|
|
102 |
| Johnson & Johnson announces research study with Apple Watch. |
|
|
165 |
| JPMorgan sees bottom forming in Semi stocks ahead of second half rally. |
|
|
137 |
| KeyCorp reports Q4 EPS 45c, consensus 48c. |
|
Financial report |
267 |
| Ladenburg reiterates Buy rating, $5 price target on Lipocine after NASH data. |
|
|
102 |
| Liberty Latin America settles insurance claims for hurricanes for $138.5M. |
|
|
197 |
| Ligand business model improving despite 60% share selloff, says H.C. Wainwright. |
|
|
202 |
| Limbach awarded contracts totaling $81.4M for hospital construction. |
|
|
162 |
| Lipocine's NASH therapy candidate achieves meaningful liver fat reduction. |
|
|
328 |
| LM Funding spikes 53% after completing IIU acquisition, sees accretion in 2019. |
|
|
211 |
| M&T Bank reports Q4 net operating EPS $3.79, consensus $3.50. |
|
Financial report |
113 |
| MacroGenics announces presentation of data on margetuximab/pembrolizumab combo. |
|
|
322 |
| Medtronic enrolls first patient in Embrace TDD clinical study. |
|
Clinical report |
113 |
| Money market rates have eased slightly. |
|
|
195 |
| Morgan Stanley reports FY ROE 11.8%, ROTCE 13.5%. |
|
|
101 |
| Morgan Stanley reports Q4 FICC sales and trading revenue $564M. |
|
Financial report |
335 |
| MSG Networks 7% pullback on Disney report unwarranted, says Imperial Capital. |
|
|
148 |
| Nautilus 'confident' market fundamentals 'solid and remain intact'. |
|
|
214 |
| Nautilus COO Bill McMahon scaling back responsibilities for health issue. |
|
|
208 |
| Nautilus sees Q4 EPS 49c-50c, consensus 56c. |
|
Financial report |
140 |
| Nautilus sees Q4 EPS 4c-5c, consensus 56c. |
|
Financial report |
142 |
| NCI Building enters into unit puchase agreement with Environmental Materials. |
|
|
111 |
| Nutanix checks show 'strong' billings this quarter, says William Blair. |
|
|
103 |
| Ocean Power receives $900,000 in non dilutive funding from NJ program. |
|
|
101 |
| Omeros finalizes clinical plan for OMS721 submission with FDA. |
|
|
268 |
| On Semiconductor stocks, Citi says 'time to step in'. |
|
|
125 |
| Pain Therapeutics enters academic collaboration with UT Austin. |
|
|
118 |
| PayPal merchant acceptance lead widened in Q4, says Morgan Stanley. |
|
|
147 |
| Pelosi says House will vote on more shutdown bills next week, WSJ says. |
|
|
103 |
| PNC Financial price target lowered to $150 from $155 at RBC Capital. |
|
|
103 |
| PPG Industries says U.S. dollar stronger in Q4 than previous year. |
|
|
130 |
| PPG says expects to deliver at least $70M in cost savings in 2019. |
|
|
128 |
| PPG sees FX unfavorably affecting sales by $400M-$500M in 2019. |
|
|
119 |
| PPG sees Q1 EPS $1.18-$1.23, consensus $1.43. |
|
Financial report |
106 |
| Puma Biotechnology initiated with a Market Perform at Leerink. |
|
|
115 |
| Rafael Holdings announces study plan for devimistat with Folfirinox trial. |
|
|
147 |
| Raytheon awarded $434M contract modification for SPY-6 AIM-9X tactical missiles. |
|
|
129 |
| Regulatory developments could impact Flipkart ability to compete, says Oppenheimer. |
|
|
108 |
| Riverview Financial appoints Ginger Kunkel COO. |
|
|
117 |
| Roadrunner announces record date of January 30 for upcoming rights offering. |
|
|
165 |
| Rowan intends to convene and adjourn Court, General Meetings. |
|
|
148 |
| Sanofi: FDA committee votes on Zynquista as treatment for type 1 diabetes. |
|
|
202 |
| Sarepta price target lowered to $164 from $175 at RBC Capital. |
|
|
103 |
| Sears confirms ESL selected as winner bidder in bankruptcy auction. |
|
|
169 |
| Sears confirms ESL selected as winning bidder in bankruptcy auction. |
|
|
169 |
| Second day of call buying in Cenovus Energy continues as shares slump. |
|
|
116 |
| Sen. Grassley says Trump is leaning towards auto tariffs, FT reports. |
|
|
157 |
| Sigma Labs awarded test, evaluation program contract with AM provider. |
|
|
130 |
| Signature Bank reports Q4 EPS $2.94, consensus $2.80. |
|
Financial report |
238 |
| Signet Jewelers CEO says 'experienced reduced traffic' in December. |
|
|
188 |
| Silicon Motion price target lowered to $50 from $58 at Needham. |
|
|
121 |
| Simulations Plus company DILIsym Services awarded $1.5M Phase II NIH grant. |
|
|
121 |
| Six Flags price target lowered to $68 from $80 at Oppenheimer. |
|
|
108 |
| Size call butterfly spread in Wells Fargo after earnings. |
|
|
109 |
| Spectrum sells portfolio to Acrotech for $160M upfront cash, $140M in milestones. |
|
|
139 |
| Spectrum to reduce staff by approx. 40%. |
|
|
106 |
| Stifel lowers Oilfield Services and Equipment estimates. |
|
|
216 |
| The 3k initial claims drop to 213k. |
|
|
264 |
| The Philly Fed bounce to 17.0. |
|
|
268 |
| Third large call butterfly spread in the big cap banking names Thursday. |
|
|
106 |
| Treasury Action: yields moved up on the better than expected Philly Fed. |
|
|
111 |
| Treasury Action: yields remained elevated. |
|
|
162 |
| Treasury Market Outlook: yields are slightly richer. |
|
|
183 |
| Treasury's $13 B 10-year TIPS preview: the auction may suffer. |
|
|
180 |
| Treasury's 4- and 8-week bill auctions were solid and priced very well. |
|
|
142 |
| Turquoise Hill exceeded 2018 production guidance for copper and gold. |
|
|
236 |
| U.S. January Philly Fed manufacturing index bounced 7.9 points to 17.0. |
|
|
179 |
| Vertical spreads in VIX April contracts after the January expiration. |
|
|
139 |
| Viking selloff on Citron's Ligand report overdone, says B. Riley FBR. |
|
|
150 |
| Wells Fargo 'skeptical' of rumor that VF Corp. seeks takeover of Skechers. |
|
|
161 |
| Wells Fargo 'skeptical' of rumor that VF Corp. seeks takeover of Skechers. |
|
|
162 |
| Wells says naloxone news possible negative for Emergent, positive for Amphastar. |
|
|
109 |
| Westamerica reports Q4 EPS 71c with items, consensus 70c. |
|
Financial report |
145 |
| Western Digital price target lowered to $65 from $75 at Wells Fargo. |
|
|
110 |
| Wex to acquire Discovery Benefits for $425M. |
|
|
163 |
| Zafgen: 1.8mg ZGN-1061 dose showed greater efficacy than 0.9mg dose in trial. |
|
|
235 |
| Zymeworks reports second IND submission milestone in Eli Lilly collaboration. |
|
|
123 |
January 17, 2019
